Jonathan Stevens is Of Counsel in the Investigations and White-Collar Defense practice. Prior to joining the Orange County, CA office, Mr. Stevens worked in the firm’s Washington, D.C. office.
Mr. Stevens was former in-house counsel for a multi-national medical device company, and has broad experience in the life sciences sector. He focuses his practice on government and internal investigations, regulatory and anti-corruption compliance counseling, and white-collar litigation on behalf of pharmaceutical and medical device companies.
Mr. Stevens has extensive experience providing day-to-day compliance advice, developing and enhancing compliance programs, conducting proactive reviews and risk assessments, overseeing internal investigations, and representing companies before state and federal authorities in criminal and civil enforcement actions involving the Anti-Kickback Statute, False Claims Act, and other state and federal healthcare statutes. He has experience, as both outside and in-house counsel, advising companies under deferred prosecution agreements with the U.S. Department of Justice and corporate integrity agreements with the U.S. Department of Health and Human Services, Office of the Inspector General. Much of his practice is currently focused on unique market access challenges, including around patient support/assistance programs, specialty pharmacy arrangements, field reimbursement support, and the full range of interactions between manufacturers, prescribers, third-party vendors, patients, and payers.
Mr. Stevens has also conducted and managed significant foreign investigations, and has represented large multi-national companies in criminal enforcement actions before the Department of Justice involving the Foreign Corrupt Practices Act. Clients routinely rely on his unique insight and perspective into the Latin American region, and benefit from him having lived in Brazil and performing legal services in Portuguese and Spanish.
Admitted in the District of Columbia and Florida only. Not admitted in California.
Investigations and White Collar Defense
Risk Assessments and Diligence
Monitorships and Compliance Counseling
Key Takeaways From the Novartis 345 Million Dollar FCPA Settlement
July 01, 2020
Compliance in the Era of COVID-19 – Where and How Life Sciences and Health Care Companies Should Focus in the Era of Social Distancing
April 22, 2020